Serotype Specificity
Serotype Specificity - Related Videos
09:11
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
0 Views •
Cited by 32 •
2014
Latex agglutination testing is a simple, rapid and inexpensive method for serotyping Streptococcus pneumoniae, and has also been widely applied in diagnostic microbiology. This manuscript describes the in-house production of latex agglutination reagents, quality control procedures and the application of this technique to pneumococcal serotyping.
04:25
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
0 Views •
Cited by 86 •
2014
The Quellung reaction is the gold standard technique for serotyping Streptococcus pneumoniae. This technique utilizes a microscope and specific pneumococcal antisera and is commonly used in reference and research laboratories worldwide.
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
0 Views •
Cited by 1 •
2015
Here, we present a protocol to generate a proof-of-principle divalent adenovirus type 5 (Ad5) vector Ad5/H5-HVR1-KWAS-HVR5-His6 by utilizing the Antigen Capsid-Incorporation strategy. This vector was demonstrated to exhibit qualitative fitness, the capability to escape Ad5-positive sera in vitro, and the antigenicity as well as immunogenicity to the incorporated antigens.
06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
0 Views •
Cited by 9 •
2018
Here we describe the delivery of microRNA using a recombinant adeno-associated virus serotype 9 in a mouse model of a neuromuscular disease. A single peripheral administration in mice resulted in sustained miRNA overexpression in muscle and motor neurons, providing an opportunity to study miRNA function and therapeutic potential in vivo.
19:02
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
0 Views •
Cited by 29 •
2011
In this article, we describe the identification of the adeno-associated virus serotype 3 (AAV3) as the most efficient vector for targeting human liver cancer cells.
FAQs
Small differences in surface antigens can change how a biological agent interacts with molecular receptors and antibodies. These altered interactions may influence receptor binding, tissue tropism, and immune recognition, even when the serotypes belong to the same species. For bioengineers, connecting antigen structure with these functional outcomes helps explain why closely related variants can perform differently in biological systems.
Receptor binding helps determine which cells or tissues a serotype can interact with, making it an important factor in tissue tropism. If related serotypes bind receptors differently, they may show distinct biological behavior and delivery patterns. This comparison is therefore useful when selecting or designing viral vectors and other targeted systems with defined biological properties.
Antibody recognition can distinguish serotypes, but related surface antigens may also produce cross-reactivity, in which antibodies directed toward one serotype interact with another. Evaluating this relationship helps researchers anticipate whether immune responses will be narrowly specific or extend across variants. The result informs vaccine design, diagnostic interpretation, and assessment of how well a system covers circulating serotypes.
Performance may decline when a selected system does not match the serotype present in the biological setting or when multiple serotypes circulate. Limited coverage can reduce effectiveness across variants, while differences in receptor binding, tissue tropism, or antibody recognition can alter outcomes. These constraints make serotype selection and cross-reactivity analysis important during bioengineering development.
A practical selection process compares the biological properties associated with available serotypes, including receptor interactions, tissue tropism, and recognition by antibodies. Researchers can then choose a vector whose properties fit the intended delivery context and evaluate whether immune responses or circulating variants could limit performance. This approach supports vector designs with more predictable, defined behavior.
For vaccines, serotype-specific information helps researchers consider immune coverage, cross-reactivity, and the possibility that multiple variants may circulate. For diagnostics, differences in antigen recognition can support discrimination among closely related variants. In both applications, examining how antibodies interact with serotypes helps clarify expected specificity and identify limitations in coverage or interpretation.
Multiple circulating serotypes can create a mismatch between the selected design and the variants encountered in practice. Comparing their antigenic and molecular interaction differences helps identify whether one system is likely to provide limited coverage or variable performance. This evaluation is relevant to viral vectors, vaccines, diagnostics, and targeted delivery systems that require defined biological properties.